Allogene Therapeutics (NASDAQ:ALLO) Posts Earnings Results, Beats Expectations By $0.08 EPS
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.08, FiscalAI reports. Allogene Therapeutics Trading Down 6.1% Shares of NASDAQ ALLO traded down $0.16 during midday trading on Thursday, reaching $2.47. The company’s [...]